Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-30 Purchase | 2026-11-03 6:09 pm | Bambusa Therapeutics Inc. | BBTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2,953,820 | $15.79 | $46,639,957 | 1,495,971 (Indirect) | View |
| 2026-11-02 Purchase | 2026-11-02 4:07 pm | Bambusa Therapeutics Inc. | BBTX | Salvia Investment GmbH 10% Owner | 375,000 | $16 | $6,000,000 | 9,264,301 (Direct) | View |
| 2026-11-02 Purchase | 2026-11-02 4:06 pm | Bambusa Therapeutics Inc. | BBTX | Jeggle Helmut Wolfgang Director 10% Owner | 375,000 | $16 | $6,000,000 | 9,264,301 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-11-02 Conversion | 2026-11-03 6:09 pm | N/A N/A | Bambusa Therapeutics Inc. | BBTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 8,951,876 | $0 | 1,495,971 (Indirect) | View |
| 2026-11-02 Conversion | 2026-11-02 4:07 pm | N/A N/A | Bambusa Therapeutics Inc. | BBTX | Salvia Investment GmbH 10% Owner | 9,539,402 | $0 | 9,264,301 (Direct) | View |
| 2026-11-02 Conversion | 2026-11-02 4:06 pm | N/A N/A | Bambusa Therapeutics Inc. | BBTX | Jeggle Helmut Wolfgang Director 10% Owner | 9,539,402 | $0 | 9,264,301 (Indirect) | View |
| 2026-11-02 Conversion | 2026-11-02 4:04 pm | N/A N/A | Bambusa Therapeutics Inc. | BBTX | Xu Shanshan MiNeng Inc. See remarks 10% Owner | 327,192 | $0 | 7,562,518 (Indirect) | View |
| 2026-10-29 Option Award | 2026-11-02 4:01 pm | N/A 2036-10-28 | Bambusa Therapeutics Inc. | BBTX | Xu Shanshan See remarks 10% Owner | 1,137,306 | $0 | 1,137,306 (Direct) | View |
Ownership | 2026-10-29 4:34 pm | N/A N/A | Bambusa Therapeutics Inc. | BBTX | Salvia Investment GmbH 10% Owner | 0 | $0 | 8,889,301 (Direct) | View |
Ownership | 2026-10-29 4:33 pm | N/A N/A | Bambusa Therapeutics Inc. | BBTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 4,475,938 (Indirect) | View |
Ownership | 2026-10-29 4:33 pm | N/A N/A | Bambusa Therapeutics Inc. | BBTX | Jeggle Helmut Wolfgang Director 10% Owner | 0 | $0 | 8,889,301 (Indirect) | View |
Ownership | 2026-10-29 4:31 pm | N/A 2036-07-09 | Bambusa Therapeutics Inc. | BBTX | Liang Howard Director | 0 | $0 | 153,908 (Direct) | View |
Ownership | 2026-10-29 4:28 pm | N/A 2036-09-17 | Bambusa Therapeutics Inc. | BBTX | Lieber Jonathan I Chief Financial Officer | 0 | $0 | 440,282 (Direct) | View |
Ownership | 2026-10-29 4:27 pm | N/A 2034-12-18 | Bambusa Therapeutics Inc. | BBTX | Ho Minh Quoc Thang See remarks | 0 | $0 | 673,383 (Direct) | View |
Ownership | 2026-10-29 4:26 pm | N/A N/A | Bambusa Therapeutics Inc. | BBTX | Xu Shanshan MiNeng Inc. See remarks 10% Owner | 0 | $0 | 8,815,100 (Indirect) | View |